Expression of the prion protein family member Shadoo causes drug hypersensitivity that is diminished by the coexpression of the wild type prion protein.

Nyeste, Antal and Bencsura, Petra and Vida, István and Hegyi, Zoltán and Homolya, László and Ayaydin-Fodor, Elfrieda and Welker, Ervin (2016) Expression of the prion protein family member Shadoo causes drug hypersensitivity that is diminished by the coexpression of the wild type prion protein. Journal of Biological Chemistry, 292 (9). pp. 4473-4486. ISSN 0021-9258 (print) 1083-351X (online)

Preview

Text J._Biol._Chem._2016_Nyeste_4473_86_u.pdf Download (3MB) | Preview

Abstract

The prion protein (PrP) seems to exert both neuroprotective and neurotoxic activities. The toxic activities are associated with the C-terminal globular parts in the absence of the flexible N-terminus, specifically, the hydrophobic domain (HD) or the central region (CR). The wild type prion protein (PrP-WT), having an intact flexible part, exhibits neuroprotective qualities by virtue of diminishing many of the cytotoxic effects of these mutant prion proteins (PrPDeltaHD, PrPDeltaCR) when coexpressed. The prion protein family member Doppel, which possesses a three dimensional fold similar to the C-terminal part of PrP is also harmful to neuronal and other cells in various models; a phenotype that can also be eliminated by the coexpression of PrP-WT. In contrast, another prion protein family member, Shadoo (Sho), a natively disordered protein possessing structural features similar to the flexible N-terminal tail of PrP, exhibits PrP-WT-like protective properties. Here, we report that contrary to expectations, Sho expression in SH-SY5Y or HEK293 cells induces the same toxic phenotype of drug hypersensitivity as PrPDeltaCR. This effect is exhibited in a dose-dependent manner and is also counteracted by the coexpression of PrP-WT. The opposing effects of Shadoo in different model systems revealed here may be explored to help discern the relationship of the various toxic activities of mutant PrP-s with each other and the neurotoxic effects seen in neurodegenerative diseases, such as transmissible spongiform encephalopathy and Alzheimer's.

Actions (login required)

Edit Item